Search results for "immunoglobulin G"

showing 10 items of 308 documents

The mechanism of binding staphylococcal protein A to immunoglobin G does not involve helix unwinding.

1996

Structural changes in staphylococcal protein A (SpA) upon its binding to the constant region (Fc) of immunoglobulin G (IgG) have been studied by nuclear magnetic resonance and circular dichroism (CD) spectroscopy. The NMR solution structure of the engineered IgG-binding domain of SpA, the Z domain (an analogue of the B domain of SpA), has been determined by simulated annealing with molecular dynamics, using 599 distance and dihedral angle constraints. Domain Z contains three alpha-helices in the polypeptide segments Lys7 to His18 (helix 1), Glu25 to Asp36 (helix 2), and Ser41 to Ala54 (helix 3). The overall chain fold is an antiparallel three-helical bundle. This is in contrast to the previ…

Models MolecularCircular dichroismProtein FoldingMagnetic Resonance SpectroscopyStereochemistryMolecular Sequence DataPlasma protein bindingDihedral angleBiochemistryProtein Structure SecondaryProtein structureComputer GraphicsAmino Acid SequenceBinding siteStaphylococcal Protein ABinding SitesChemistryCircular DichroismNuclear magnetic resonance spectroscopyRecombinant ProteinsImmunoglobulin Fc FragmentsModels StructuralCrystallographyIgG bindingImmunoglobulin GMutagenesis Site-DirectedProtein foldingProtein BindingBiochemistry
researchProduct

Modeling of the role of conformational dynamics in kinetics of the antigen-antibody interaction in heterogeneous phase.

2012

[EN] A novel approach that may potentially be used to study biomolecular interactions including the simultaneous determination of structural and kinetic binding parameters is described in this Article for the first time. It allows a rigid distinction between the possible reaction mechanisms of biomolecular recognition, induced fit and conformational selection. The relative importance of the two pathways is determined not by comparing rate constants but the structural aspects of the interaction instead. So the exact location of antigen molecules with respect to the capture antibody is depicted experimentally, avoiding the use of X-ray crystallography. The proposed pattern is applied to study…

Models MolecularTime FactorsSimultaneous determinationsProtein ConformationRate constantsBinding processAntigen-Antibody ComplexImmunoglobulin GFragment antigen-bindingConformational dynamicsMiceStructural aspectsBiomolecular recognitionMaterials ChemistrySteric hindrancesBovine serum albuminReaction mechanismbiologyChemistryIn-situSerum Albumin BovineLigand (biochemistry)Reaction schemesSurfaces Coatings and FilmsConformationsAntigen-antibody interactionBovine serum albuminsBiomolecular interactionsMolecular recognitionBSA moleculesAlgorithmsProtein BindingStereochemistryKinetic bindingReaction intermediateAntigen bindingAntibodiesMolecular recognitionAntigenQUIMICA ANALITICAAnimalsComputer SimulationPhysical and Theoretical ChemistryAntigensHeterogeneous phaseInduced fitX ray crystallographyMoleculesSensing surfaceKineticsSilicon chipInterferometryConformational selectionImmunoglobulin Gbiology.proteinBiophysicsCattleAntigen-antibody interactionThe journal of physical chemistry. B
researchProduct

Expansion of intracellular IFN-γ positive lymphocytes during Mycoplasma agalactiae infection in sheep.

2010

Abstract A method to assess the expansion of antigen-specific intracellular IFN-γ positive T cell subsets during the infection will be helpful for a better understanding of mycoplasmal infections physiopathology in the sheep. We analysed the percentage of antigen-specific lymphocytes positive for intracellular IFN-γ during the infection of sheep with Mycoplasma agalactiae by culturing peripheral blood mononuclear cells of infected or uninfected animals with irradiated M. agalactiae . The expansion of antigen-specific IFN-γ positive lymphocytes in infected sheep was initially sustained by CD4 + T cells at day 15 after infection, when antigen specific IgG start to be detectable, followed by C…

Mycoplasma agalactiaeT cellved/biology.organism_classification_rank.speciesDouble negativeSheep DiseasesBiologyPeripheral blood mononuclear cellMycoplasma agalactiaeInterferon-gammaImmunityAntibody SpecificitymedicineCytotoxic T cellAnimalsMycoplasma InfectionsLymphocytesAgalactia Mastitis T cells Peripheral blood mononuclear cells CD4+ cells CD8+ cellsAntigens BacterialSheepGeneral Veterinaryved/biologyAntibodies Bacterialmedicine.anatomical_structureImmunoglobulin GImmunologyLeukocytes MononuclearIntracellularCD8Research in veterinary science
researchProduct

Safety and Pharmacokinetics/Pharmacodynamics of the First-in-Class Dual Action HER3/EGFR Antibody MEHD7945A in Locally Advanced or Metastatic Epithel…

2015

Abstract Purpose: The novel dual-action humanized IgG1 antibody MEHD7945A targeting HER3 and EGFR inhibits ligand-dependent HER dimer signaling. This phase I study evaluated the safety, pharmacokinetics, pharmacodynamics, and antitumor activity of MEHD7945A. Experimental Design: Patients with locally advanced or metastatic epithelial tumors received escalating doses of MEHD7945A (1–30 mg/kg) every 2 weeks (q2w) until disease progression or intolerable toxicity. An expansion cohort was enrolled at the recommended phase II dose (14 mg/kg, q2w). Plasma samples, tumor biopsies, FDG-PET were obtained for assessment of pharmacokinetics, and pharmacodynamic modulation downstream of EGFR and HER3. …

OncologyAdultMaleCancer Researchmedicine.medical_specialtyDrug-Related Side Effects and Adverse ReactionsReceptor ErbB-3Colorectal cancerCetuximabPharmacologyAntibodies Monoclonal HumanizedEGFR AntibodyArticleErlotinib HydrochloridePharmacokineticsInternal medicineCarcinoma Non-Small-Cell LungAntineoplastic Combined Chemotherapy ProtocolsmedicineCarcinomaPanitumumabHumansAgedDose-Response Relationship Drugbusiness.industrySquamous Cell Carcinoma of Head and NeckPanitumumabCancerAntibodies MonoclonalMiddle Agedmedicine.diseaseErbB ReceptorsOncologyHead and Neck NeoplasmsPharmacodynamicsImmunoglobulin GCarcinoma Squamous CellChillsFemalemedicine.symptombusinessmedicine.drugClinical cancer research : an official journal of the American Association for Cancer Research
researchProduct

A hantavirus nucleocapsid protein segment exposed on hepatitis B virus core particles is highly immunogenic in mice when applied without adjuvants or…

2005

Hepatitis B virus (HBV) core particles carrying the amino-terminal 120 amino acids (aa) of the nucleocapsid (N) protein of the hantaviruses Dobrava, Hantaan or Puumala have been demonstrated to be highly immunogenic in mice when complexed with adjuvants. Here we demonstrate that even without adjuvant, these chimeric particles induced high-titered, and strongly cross-reactive N-specific antibody responses in BALB/c and C57BL/6 mice. The induced N-specific antibodies represented all IgG subclasses. Pre-existing core-specific antibodies did not abrogate the induction of an N-specific immune response by a hantavirus N insert presented on core particles. Therefore, chimeric core particles should…

Orthohantavirusmedicine.medical_treatmentEnzyme-Linked Immunosorbent AssaySaccharomyces cerevisiaeCross Reactionsmedicine.disease_causeAntibodies ViralVirusMiceOrthohepadnavirusAdjuvants ImmunologicmedicineEscherichia coliAnimalsImmunization ScheduleHantavirusHepatitis B virusMice Inbred BALB CVaccines SyntheticGeneral VeterinaryGeneral Immunology and MicrobiologybiologyImmunogenicityPublic Health Environmental and Occupational Healthvirus diseasesNucleocapsid Proteinsbiology.organism_classificationVirologyHepatitis B Core AntigensMice Inbred C57BLInfectious DiseasesHepadnaviridaeImmunoglobulin Gbiology.proteinMolecular MedicineFemaleAntibodyCarrier ProteinsAdjuvantPlasmidsVaccine
researchProduct

Immunofluorescence studies on the subcomponents of the first component of complement (C1): detection of C1q and C1s in different cells of biopsy mate…

1981

The first component of complement (C1) is a macromolecule consisting of three distinct subcomponents, C1q, C1r, and C1s. In regard to its production site and its role in phagocytic processes it was of interest to find out whether these different subcomponents could be detected in human biopsy material only as a complex in individual cells or whether C1 subcomponents could be found on different cells. To study this question, monospecific fluorescein-labelled anti-human-C1q IgG and monospecific rhodamine-labelled anti-human C1q IgG were used. Biopsy material from human rectum was stained with fluoresceinated antisera, either by use of one antiserum or by double staining. Using this technique,…

Pathologymedicine.medical_specialtyImmunologyGuinea PigsFluorescent Antibody TechniqueImmunofluorescenceImmunoglobulin GAntibodiesGuinea pigCell membraneComplement C1medicineImmunology and AllergyMacrophageAnimalsHumansAntiserumbiologymedicine.diagnostic_testMacrophagesCell MembraneRectumHematologyStainingmedicine.anatomical_structureImmunoglobulin Gbiology.proteinRabbitsAntibodyImmunobiology
researchProduct

Methotrexate as a treatment in ocular cicatricial moderate pemphigoid.

2013

Abstract Clinical case A 73 year-old woman presented with a history of non-specific symptoms and photophobia in both eyes of 1 year progression. The examination revealed a bilateral symblepharon and fornix shortening. Immunohistochemical analysis confirmed the presence of linear deposits of IgG, IgM and C3 along the conjunctival basement membrane. With the diagnosis of ocular cicatricial pemphigoid, systemic treatment with subcutaneous methotrexate was prescribed. Discussion We consider such treatment a very effective initial immunosuppressive alternative in patients with moderate conjunctival inflammation and in cases of rapid progression.

Pemphigoidmedicine.medical_specialtyPhotophobiaEtiologyMetotrexatePemphigoid Benign Mucous MembraneComplications scarHyperemiaBasement MembraneDiagnosis ocular cicatricial pemphigoidmedicineUso terapeuticoHumansOcular cicatricial pemphigoidAgedBasement membraneKeratitisbusiness.industrySymblepharonFornixTherapeutic useDiagnostico penfigoide ocular cicatricialGeneral MedicineComplement C3medicine.diseaseDermatologyeye diseasesAgentes inmunosupresoresmedicine.anatomical_structureMethotrexateImmunoglobulin MEtiologiaImmunoglobulin GEtiologyImmunohistochemistryMethotrexateComplicaciones cicatrizFemalesense organsPenfigoide ocular cicatricialmedicine.symptomImmunosuppressive agentsbusinessConjunctivaImmunosuppressive Agentsmedicine.drugArchivos de la Sociedad Espanola de Oftalmologia
researchProduct

Effects of hydrocortisone on binding of IgG or C3b-coated erythrocytes to human monocytes and polymorphonuclear leucocytes.

1979

Pharmacologymedicine.medical_specialtyPathologyErythrocytesSheepHydrocortisonebusiness.industryNeutrophilsPharmaceutical ScienceIn Vitro TechniquesChromium RadioisotopesMonocytesEndocrinologyInternal medicineImmunoglobulin GComplement C3bmedicineCell AdhesionAnimalsHumansbusinessHydrocortisonemedicine.drugThe Journal of pharmacy and pharmacology
researchProduct

CONTROLLED RELEASE OF IgG BY NOVEL UV INDUCED POLYSACCHARIDE/POLY(AMINO ACID)HYDROGELS

2009

The development of new protein and peptide drugs needs new delivery systems able to entrap such drugs in safe conditions without affecting their structure and biological activity. In this context, the present work reports a new approach to load IgG, used as a model of therapeutic proteins such as anti-TNF-alpha monoclonal antibodies, into a polymeric system able to release the entrapped IgG in a controlled manner. In particular, new polysaccharide/poly(amino acid) UV induced hydrogels are proposed as colon delivery systems for human IgG. The poly(amino acid), alpha,beta-poly[N-(2-hydroxyethyl)-D,L-aspartamide], has been functionalized with methacrylic anhydride, while the polysaccharide, in…

Polymers and PlasticsUltraviolet RaysMethacrylic anhydrideBioengineeringPeptideContext (language use)Enzyme-Linked Immunosorbent AssayBiomaterialschemistry.chemical_compoundCrohn DiseasePolysaccharidesMaterials ChemistryOrganic chemistryHumanshydrogels drug releaseAmino Acidschemistry.chemical_classificationChromatographytechnology industry and agricultureSuccinic anhydrideHydrogelsControlled releaseAmino acidchemistrySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoDelayed-Action PreparationsImmunoglobulin GSelf-healing hydrogelsChromatography GelCaco-2 CellsDrug carrierBiotechnology
researchProduct

CRISPR-Cas12a-Based Detection of SARS-CoV-2 Harboring the E484K Mutation

2021

The novel respiratory virus SARS-CoV-2 is rapidly evolving across the world with the potential of increasing its transmission and the induced disease. Here, we applied the CRISPR-Cas12a system to detect, without the need of sequencing, SARS-CoV-2 genomes harboring the E484K mutation, first identified in the Beta variant and catalogued as an escape mutation. The E484K mutation creates a canonical protospacer adjacent motif for Cas12a recognition in the resulting DNA amplicon, which was exploited to obtain a differential readout. We analyzed a series of fecal samples from hospitalized patients in Valencia (Spain), finding one infection with SARS-CoV-2 harboring the E484K mutation, which was t…

PolymersBiomedical EngineeringBiosensing TechniquesBiologyBiochemistry Genetics and Molecular Biology (miscellaneous)Genomechemistry.chemical_compoundCOVID-19 TestingPeptide LibraryTechnical NoteCRISPRCRISPR diagnosticsHumansGeneticsvirus evolutionSARS-CoV-2Epidemiological surveillanceepidemiological surveillanceCOVID-19General MedicineDNAAmpliconSurface Plasmon ResonanceVirus evolutionProtospacer adjacent motifHEK293 CellschemistryGenetic TechniquesSpainViral evolutionImmunoglobulin GMutation (genetic algorithm)DNA ViralMutationRespiratory virusCRISPR-Cas SystemsDNAACS Synthetic Biology
researchProduct